Zacks: OXiGENE Inc. (MATN) Receives Consensus Rating of "Strong Buy" from Analysts


Shares of OXiGENE Inc. have been assigned an average broker rating score of 1.00 from the one brokers that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.



from Biotech News